tiprankstipranks
Advertisement
Advertisement

Scilex Settles Debt, Expands Distribution of Non-Opioid Treatments

Scilex Settles Debt, Expands Distribution of Non-Opioid Treatments

Meet Samuel – Your Personal Investing Prophet

Scilex Holding Company ( (SCLX) ) has issued an update.

Scilex Holding Company has reached an agreement with Endeavor Distribution LLC to satisfy a $10 million loan from FSF 33433 LLC by delivering a specified quantity of their ZTlido product. This agreement not only settles the debt but further strengthens Scilex’s partnership with Endeavor, which will distribute Scilex’s non-opioid pain management products across the U.S., potentially expanding their market reach. The deal underlines Scilex’s commitment to increasing access to their non-opioid treatments, a move that is expected to benefit thousands of patients suffering from acute and chronic pain.

See more insights into SCLX stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1